Supportive Care for Patients with Systemic Light Chain Amyloidosis
Sandy W Wong1, Teresa Fogaren2
1Hematology/Blood and Marrow Transplantation, Comprehensive Amyloid Program, University of California, 400 Parnassus Avenue, San Francisco, CA 94143, USA.
Light chain amyloidosis involves toxic proteins damaging organs. Treatment targets the source cells, reducing protein buildup and improving organ function while supportive care manages symptoms and side effects.
Area of Science:
- Hematology
- Nephrology
- Cardiology
Background:
- Light chain amyloidosis is a plasma cell disorder characterized by toxic immunoglobulin light chain production.
- These light chains misfold into amyloid fibrils, depositing in vital organs like the heart and kidneys.
- Deposition can lead to progressive organ dysfunction and failure.
Purpose of the Study:
- To outline the pathophysiology of light chain amyloidosis.
- To describe current treatment strategies targeting the underlying clonal plasma cells.
- To emphasize the importance of supportive care in managing organ involvement and treatment side effects.
Main Methods:
- Review of existing literature on light chain amyloidosis.
- Analysis of treatment outcomes for patients receiving targeted therapy.
- Evaluation of supportive care protocols for symptom management.
Main Results:
- Targeted therapy eliminates clonal plasma cells, halting further amyloid deposition.
- Organ function may improve, and the risk of organ failure is reduced with effective treatment.
- Supportive care is crucial for managing symptoms and improving quality of life.
Conclusions:
- Effective treatment of light chain amyloidosis requires addressing the clonal plasma cell population.
- Supportive care is integral to the comprehensive management of patients.
- Multidisciplinary care improves outcomes and patient well-being.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Myocarditis IV: Nursing Management


